Project Grant T32TR006158
- Federal Grant Award Summary The University of Pennsylvania received a $553,631 Project Grant award from the National Center for Advancing Translational Sciences (NCATS) under CFDA 93.350, effective July 6, 2026, through May 31, 2031. The CTSA (Clinical and Translational Science Award) Predoctoral T32 program provides comprehensive training and mentorship to 10 predoctoral trainees at any given time, drawn from PhD, MD (Doctor of Medicine), DMD (Doctor of Dental Medicine), and VMD (Doctor of...
- The University of Pittsburgh's Institute for Clinical Research Education (ICRE) received a $502,465 Project Grant award from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) effective August 1, 2026, through June 30, 2031. This Clinical and Translational Science Award (CTSA) Postdoctoral T32 training program equips postdoctoral fellows with skills necessary to overcome research barriers and accelerate the translation of clinical and translational research (CTR)...
- Award Summary The University of Pennsylvania received a $10.8 million Cooperative Agreement from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) effective July 1, 2026, through May 31, 2033, to establish and operate the Penn-CHOP Clinical and Translational Science Award (CTSA) Hub. The hub will deliver integrated clinical and translational science services across four primary domains: developing and disseminating novel translational therapeutics; applying advanced...
- Federal Grant Award Summary New York University School of Medicine received a $462,079 Project Grant from the National Center for Advancing Translational Sciences (NCATS) (CFDA 93.350) awarded September 1, 2026, through August 31, 2031. The NYU Clinical and Translational Science Institute (CTSI) T32 Postdoctoral Training Program directly supports NCATS' mission to accelerate the translation of scientific discoveries into improved healthcare outcomes by developing the next generation of...
- Federal Grant Award Summary The Johns Hopkins University received a $1,095,342 Project Grant from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded September 15, 2025, with a completion date of August 31, 2030. The award funds the Clinical and Translational Science Award (CTSA) Postdoctoral T32 Training Program at Johns Hopkins University's Institute for Clinical and Translational Research (ICTR). The program provides integrated postdoctoral training in...
- The University of Rochester received a $223,364 Project Grant award dated September 12, 2025, from the National Center for Advancing Translational Sciences (NCATS) under the Clinical and Translational Science Award (CFDA 93.350) program to support its Clinical and Translational Science Institute (CTSI) T32 Predoctoral Training Program. This five-year award, with an ultimate completion date of August 31, 2030, funds a comprehensive mentored research training initiative designed to cultivate the...
- The University of Rochester received a $1.512 million Project Grant from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded August 8, 2025, to establish and operate a Clinical and Translational Science Institute (CTSI) K12 Research Career Development Program. The program will support four K12 scholars (two per year) over two-year appointments through June 30, 2030. The primary deliverables include a structured research career development curriculum in...
- Federal Grant Award Summary The Ohio State University's Office of Sponsored Programs received a $252,545 Project Grant award from the National Center for Advancing Translational Sciences (NCATS) under CFDA 93.350, effective September 17, 2025 through July 31, 2030. The award supports the establishment of a Clinical and Translational Data Science (CTDS) T32 postdoctoral training program administered by the Ohio State University Clinical and Translational Science Institute. The program delivers...
- Federal Grant Award Summary The National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded The Trustees of Columbia University in the City of New York a $275,316 Project Grant effective July 1, 2026, through May 31, 2031, to support the Irving Institute for Clinical and Translational Research's predoctoral T32 training program. This award funds the continuation of a approximately 20-year legacy of training predoctoral fellows in clinical and translational research, with...
- Duke University's Office of Research Administration received a $3.16 million Project Grant from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded August 15, 2025, through July 31, 2030. The award funds the CTSA K12 Program, an institutional career development initiative that builds upon Duke's earlier KL2 (Kirschstein-National Research Service Award Leader) program. The program provides junior faculty scholars from Duke University and North Carolina Central...
The University of Pennsylvania received a $532,701 Project Grant award from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) on July 6, 2026, to establish and operate a Clinical and Translational Science (CTS) Postdoctoral T32 Training Program. The program supports annual training of five postdoctoral fellows—two with PhDs and three clinicians—for 1–2 year periods through May 31, 2031. Trainees engage in mentored research projects embedded within an academic framework, combining rigorous research investigation with formal coursework in implementation science, data science, and learning health system science. Training incorporates structured professional development through Penn's ASCEND program, focusing on leadership and resilience, along with integration into the broader Institute for Translational Medicine and Therapeutics (ITMAT) community of over 2,000 members. The program leverages the University of Pennsylvania's established expertise in translational science workforce development built on 20 years of prior training initiatives and successful bench-to-bedside translation examples in mRNA therapeutics and cell/gene therapies. Trainees receive comprehensive mentoring through designated research mentors, program mentors, and advisory committees, with participation in research seminars, seminars-in-progress presentations, and access to the broader Cellicon Valley industrial innovation ecosystem. The initiative addresses the critical gap between scientific discovery and clinical implementation by equipping emerging investigators with the knowledge, skills, and professional networks required for careers across academic medicine, industry, nonprofits, and government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $532.7k | 7/7/26 |